AR and prostate carcinoma: Several molecular biomarkers of key prostate cancer pathogenic pathways including Ki-67 (proliferation), Bcl-2(apoptosis), CD31 (angiogenesis), Her-2/neu (oncogene), PTEN (anti-oncogene), and AR (androgen receptor) were also involved in this study.